“We must anticipate the third wave.” 202 million doses planned for March



[ad_1]

Covid vaccine, first doses of Pfizer in Italy between January 23 and 26:

Vaccine anti-COVID-19 from Pfizer in Italy “between January 23 and 26”. The doses (the first section will be equal to 3.4 million sera) “will go to the 300 points identified, which are directly the hospitals.” This was reported by the Minister of Health, Roberto Speranza, to the leaders of the group at the meeting in Palazzo Chigi. The minister explained the need for «no make the third wave coincide with the vaccination campaign ”. The Pfizer vaccine will be submitted for evaluation by the EMA (the EU drug regulatory body) on December 29. “202 million doses of vaccines” are expected from the first quarter of 2021.

The lines of the vaccination plan

Anticipating the lines of the Vaccini Plan, Speranza would have expressed the strategic importance of flexing the epidemiological curve. The goal is not to start with the obligation in the vaccination campaign against Covid but with the persuasion and information to achieve herd immunity with 40 million Italians.

“202 million doses of vaccine” against Covid will be available from the first quarter of 2021; each dose, according to current knowledge, “needs a boost and we don’t know how much immunity there is.”

Mass vaccinations against Covid will take place in large public spaces, gyms, open spaces, and fairs. The distribution of the vaccine, majority sources have announced, will be entirely state: management will be centralized and the vaccine will be distributed in accordance with medical and scientific decisions.

First, the vaccine will go to medical and healthcare personnel and to RSA. Regarding the age range, first those over 80, then the 60/70 group and gradually the other groups, such as essential workers, including school. Based on the initial information, I plan to implement the network to monitor vaccines with a dedicated information system, connected to the regional systems. But also a double vaccination and immunological surveillance.

Video

Last updated: 21:03


© REPRODUCTION RESERVED



[ad_2]